United States · Bill · S
S. 1191 (104th)
Consumer Access to Prescription Drugs Act of 1995
Introduced
11 August 1995
Last action
—
Status
Read twice and referred to the Committee on Labor and Human Resources.
Sponsors
—
Subjects
Discovery layer
Source updated
21 August 2025
Summary
Consumer Access to Prescription Drugs Act of 1995 - Regulates the patent expiration date regarding new drug and new animal drug applications submitted before June 8, 1995 (or submitted after that date but with substantial investment before that date). Declares that the remedies of certain patent provisions shall not apply to acts that were commenced (or that had substantial investment) before that date and that became infringing by reason of specified provisions of the Uruguay Round Agreements Act. Restricts the circumstances in which equitable remuneration may be awarded. Sets forth what constitutes: (1) acts commenced prior to that date; and (2) substantial investment. Specifies the application approval and judicial circumstances to which this Act applies.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate (text)
Introduced in Senate · EN · 11 August 1995
Introduced in Senate (PDF)
Introduced in Senate · EN · 11 August 1995
Introduced in Senate
summary · EN · 11 August 1995
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/104th-congress/senate-bill/1191
- Open data entity: https://api.congress.gov/v3/bill/104/s/1191